key: cord-0730732-m2vlmjtj
authors: Bartha, F. A.; Karsai, J.; Tekeli, T.; Röst, G.
title: Symptom-based testing in a compartmental model of COVID-19
date: 2020-10-14
journal: nan
DOI: 10.1101/2020.10.11.20211037
sha: cdbbffa08820bc8fac849d1f5aafcdaf6e3feb0d
doc_id: 730732
cord_uid: m2vlmjtj

Testing and isolation of cases is an important component of our strategies to fight SARS-CoV-2. In this work, we consider a compartmental model for COVID-19 including a nonlinear term representing symptom-based testing. We analyze how the considered clinical spectrum of symptoms and the testing rate affect the outcome and the severity of the outbreak.

Since a cluster of pneumonia cases of unknown origin was discovered in Wuhan, China in late 2019, COVID-19, the disease caused by the novel coronavirus SARS-CoV-2, has spread around the world giving rise to a pandemic. By early August 2020, around eighteen million cases and seven hundred thousand deaths have been reported worldwide [1] .

One of the key difficulties in controlling COVID-19 is that many infections result in mild symptoms or none at all, making the detection of infectious COVID-19 cases particularly challenging [2] . Moreover, a considerable portion of secondary infections, generated by those infectors who later develop symptoms, have been observed to take place before symptom onset, i.e. pre-symptomatic transmission occurs [3, 4, 5] .

COVID-19 is classified as a respiratory disease, accordingly, it mainly affects the respiratory tract (similarly to other coronaviruses) but other classes of symptoms have been observed as well, e.g. affecting the gastrointestinal [6] and musculoskeletal systems [7] . In particular, the loss of smell (anosmia) and/or taste (ageusia) could be a key indicator symptom of COVID-19 [8] . We summarize findings of some recent studies regarding COVID-19 symptoms and their prevalence among clinical COVID-19 cases in Table 1 . The primary confirmation of COVID-19 infection, as of now, happens via real-time reverse transcription polymerase chain reaction (rRT-PCR) based testing of samples taken from e.g. nasopharyngeal or oropharyngeal swabs, sputum, lower respiratory tract aspirates, etc [11] .

A classical approach for modeling and understanding epidemics is constructing a system of ordinary differential equations (ODE) having a compartmental structure. Also, such models are widely utilized as an important tool of assessing the effectiveness of various control strategies [13, 14] .

In particular, the transmission dynamics of the spread of COVID-19 has been analyzed via compartmental ODE models in a vast number of studies. Yang and Wang [15] investigated the outbreak of COVID-19 in Wuhan, China considering multiple transmission pathways in the infection dynamics. Non-constant transmission rates were employed, changing with the epidemiological status and environmental conditions reflecting the impact of the ongoing disease control measures. Boldog et al. [16] developed a tool comprised of three major components to assess the risk of global spread of COVID-19 with origin from Wuhan. A time-dependent SEIR model (Suceptible-Exposed-Infectious-Removed) was used to estimate the cumulative number of cases in China from which probability distributions were obtained for the number of potential disease spreaders outside China. Finally, for a given destination country, the initial spread of COVID-19 was approximated via a Galton-Watson process. Berger et al. [17] utilized an extended SEIR model to understand the role of testing and case-dependent quarantine with fixed rates and compared simple testing and quarantine policies. Weitz [18] developed an extended, age-stratified model analyzing both asymptomatic and severe courses of the disease in order to estimate the burden on the healthcare system by modeling hospital and intensive care unit (ICU) bed needs. Röst et al. [19] studied an age-stratified compartmental model and presented a comprehensive analysis exploring several post-lockdown scenarios with age-specific measures, seasonality, and spatial heterogeneity.

In this work, we consider an extended SEIR-type compartmental model for the transmission dynamics of COVID-19. We incorporate symptombased testing of patients and isolation upon positive result i.e. removal from the infectious chain. The clinical symptoms that trigger the testing of individuals is referred to as indicator symptom. The force of testing is defined as the rate at which infected individuals are tested, see Sect. 2. It is described by a nonlinear function of the state of the epidemic and of all individuals displaying the indicator symptom at a given time, with or without COVID-19 infection, hence, it is considerably different from previous approaches. Our goal is to understand the impact, and especially the limitations of this testing strategy, hence we model neither contact-tracing of patients with positive tests nor the testing of a fraction of non-symptomatic contacts, both of which are common and efficient improvements and result in removal of additional patients from the infectious chain. Moreover, we assume perfect testing, that is we do not consider false positive or false negative results.

According to the current understanding of the disease, none of the symptoms are specific solely for COVID-19, thus, the chosen indicator symptom may and will be present amongst other individuals not infected with SARS-CoV-2. All patients, with or without COVID-19 infection, displaying the indicator symptom form the so-called primary symptom pool, whilst, those without COVID-19 infection (but with the same indicator symptom) are members of the secondary symptom pool, see Sect. 2. Naturally, choosing the indicator symptom for a testing campaign should be affected by its prevalence and by the historical statistics for the size of the associated secondary symptom pool. We emphasize that the latter might undergo seasonal variations as is typical with respiratory symptoms peaking in influenza season [20] . This is a common but not uniform feature of COVID-19 symptoms, e.g. gastrointestinal symptoms might show no seasonal variations, depending on age-groups [21] . epidemic model and its parametrization. In addition, the next generation matrix computations are included that are used to derive formulae for the reproduction number. Then, Sect. 3 establishes several boundedness and monotonicity-type results on key characteristics of the epidemic model. The results of numerical simulations are discussed in Sect. 4. Finally, we present our conclusions in Sect. 5.

To assess the effectiveness of indicator symptom based testing in controlling the spread of COVID-19, we developed a compartmental population model based on the general SEIR formulation without vital dynamics. We divide the population into five classes: susceptible (S), latent (L), pre-symptomatic (P ), infected (I), and removed (R). Susceptibles are those who can get infected by SARS-CoV-2. The members of the latent compartment L have already been infected, but are not yet infectious nor do they display any symptoms. After that, latent individuals move to the presymptomatic class P meaning that, due to the increased viral load, they are able to infect susceptible individuals, even though, they still not display any symptoms. The existence of pre-symptomatic transmission is of particular importance in analyzing COVID-19 as it is one of the key features of the disease that makes controlling the outbreak difficult. Then, in our model, after the incubation period, at disease onset, members of P move to the infected class I. We note that another challenge with COVID-19 is that many patients will develop mild symptoms or none at all, yet being infectious. It is thus customary to collect these individuals in a separate compartment of asymptomatic individuals [18, 19] . Nevertheless, this distinction is not needed in our model as we will explain later in this section. Finally, patients transit to the removed compartment R by either recovery or by isolation after testing positive for COVID-19.

The above considerations are formulated in the following system of or-4 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 14, 2020. . dinary differential equations

,

The disease transmission rate is denoted by the parameter β, the incubation period is α −1 +ρ −1 , which is the sum of the duration of the latent period and the pre-symptomatic period, and, finally, γ −1 stands for the symptomatic infectious period. The transmission diagram of (1) is depicted on Fig. 1 . The force of infection is the rate associated with the outward flow from S to L, namely,

The indicator symptom-based testing is represented by the term

where k gives the number of tests done per unit time also referred to as the testing rate, the probability p describes how likely is that a member of compartment I displays the chosen indicator symptom. Note that this probability removes the need for an asymptomatic/mild compartment as it is straightforward to adjust p to account for all COVID-19 patients. The

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.11.20211037 doi: medRxiv preprint final term σ (possibly time-dependent) represents those individuals who are not infected by COVID-19, yet they show the very same symptom we base our testing upon. In this chapter, we refer to σ as the secondary symptom pool, whereas, the primary symptom pool Σ is composed of all members (with or without COVID-19 infection) of the population displaying the indicator symptom at a given time, that is

The testing rate k has a natural upper bound, namely, k ≤ Σ as we solely test patients displaying the indicator symptom. By reformulating the testing term as

it is interpreted as the removal of the k Σ fraction of COVID-19 patients displaying the indicator symptom.

The rate of the testing-induced outward flow from I to R is referred to as the force of testing given by

Finally, we introduce the positivity rate of testing as

that may serve as a real-time indicator of the severity of an ongoing epidemic, and the adequateness of the testing rate. Note that (1) is, in part, simpler than many other variants that have been used to assess the spread of COVID-19 as the infectious and latent compartments are not split into multiple stages [16, 18, 19, 22, 23] . However, these additional classes carry little significance for the testing strategies and to the analysis presented in this chapter. Hence, we chose to use this less complicated structure so that the emphasis is put on the testing itself.

We have parametrized (1) following [14] . From the infectivity profile of COVID-19 [3, 4, 5] , we can see that most transmissions occur between 3 days prior to and 4 days after symptom onset, with the pre-symptomatic infection fraction being 43.7%. Thus, it is a reasonable approximation to set 6 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . the pre-symptomatic period ρ −1 as 3 days, and the symptomatic infectious period γ −1 as 4 days, with the same infectiousness β during this period. The estimated mean incubation period of COVID-19 is 5.5 days [24] , thus, the latent period α −1 is taken as 2.5 days, see Table 2 . The choice of the transmission rate β is discussed in Sect. 2.1 and the testing parameters k, p, σ are varied throughout the analysis. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. .

Now, we concentrate on establishing the relationship between the transmission rate β in (1) and the basic reproduction number R 0 of the epidemic. We shall follow the terminology and techniques of [25] to compute the Next Generation Matrix (NGM) and the R 0 as its spectral radius.

First, let us consider the infectious subsystem of (1), namely, equations describing L(t), P (t), and I(t). Linearizing this subsystem w.r.t. the disease free equilibrium yields the linearized infectious subsystem

where the matrices F and V are referred to as the transmission part and transitional part, respectively; the state is described by

The transmission matrix F has the form

and the transitional matrix V is, clearly, written as

The basic reproduction number R 0 is then obtained by computing the spectral radius of −FV −1 that is

Therefore, as

it follows that

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . providing a scheme for computing β. We list the corresponding transmission rates for the sample values of R 0 used for illustrations in Table 3 .

The basic reproduction number R 0 is descriptive for the epidemic at the very beginning of an outbreak and in absence of control measures. For simplicity, we use the phrase basic reproduction number even if social distancing is in place, and by control measure in this chapter we mean the testing, the absence of which is modeled by k = 0. Similar key characteristics are the control reproduction number R c and the effective reproduction number R t . The former describes the epidemic incorporating the effect of interventions, in our case indicator symptom-based testing, but still at the beginning of the outbreak. In contrast, the latter is suitable to measure the spread of the disease as the epidemic is progressing. The corresponding formulae may be obtained via analogous computations to those above as

and

As the testing rate k is bound by the size of the primary symptom pool Σ, it is apparent that both of the above reproduction numbers satisfy

3 Dependence of key epidemic quantities on the testing strategy

This section analyzes the symptom-based testing strategy with emphasis on how the force of testing and the effective reproduction number are affected by the particular choice of strategy. Repeatedly, we shall utilize the 9 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.11.20211037 doi: medRxiv preprint monotonicity of

where 0 < a ≤ b and 0 ≤ x.

First, we summarize trivial monotonicity properties of the force of testing τ k,p,σ .

Proposition 3.1. Given a fixed state of (1), the force of testing τ k,p,σ is a) monotonically increasing in k, b) monotonically increasing in k Σ . In particular, as τ k,p,σ = kp Σ , if k Σ = const, then τ k,p,σ = const, i.e. the force of testing strongly correlates to what portion of the primary symptom pool is being tested.

As the epidemic is progressing, we may want to maintain the force of testing by increasing the testing rate k that is testing the same portion of individuals displaying the indicator symptom. Clearly, the required adjustment is linear w.r.t. the size of compartment I, thus, the given constant force of testing may be maintained as long as other logistical constraints make increasing the testing rate feasible.

The choice of the indicator symptom that serves as a basis for selecting patients for testing is clearly of importance. Different indicator symptoms typically have different associated probabilities and secondary symptom pools of non-equal sizes. Thus, it is natural to ask what (p, σ) pair is optimal.

Proposition 3.2. The force of testing τ k,p,σ is monotonically decreasing in σ p . Proof. Clearly,

that, in turn, simplifies to σ 2 p 2 ≤ σ 1 p 1 yielding the required result.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. .

As we have seen, keeping the fraction k Σ constant results in constant force of testing τ k,p,σ . The authorities might obtain some data on the size of the primary symptom pool Σ during an outbreak and use this information for adjusting k on-the-go. When planning for a second wave, historical data on the size of the secondary symptom pool σ may give information on the required level of preparedness. Namely, if we know that σ has now a different size compared to the former outbreak, e.g. due to a seasonal variation, we may utilize the size difference of the secondary symptom pools as a guidance for the need for testing capacities as follows. Proposition 3.3. Given a fixed state of (1), consider two secondary symptom pools, 0 ≤ σ 1 ≤ σ 2 for the same indicator symptom that appears amongst members of the compartment I with probability p. Let k 1 and k 2 be two testing rates corresponding to the testing strategies for σ 1 and σ 2 , respectively. Then,

Proof. As the state is fixed, the two strategies having equal effect corresponds to the equality k 1 p pI + σ 1 = τ k 1 ,p,σ 1 = τ k 2 ,p,σ 2 = k 2 p pI + σ 2 that simplifies to k 2 k 1 = pI + σ 2 pI + σ 1 .

Then, using the aforementioned monotonicity of f (x), we obtain

Finally, the monotonicity of τ k,p,σ in k completes the proof.

Recall, that the force of testing τ k,p,σ explicitly appears in the formula for the effective reproduction number R t as

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . Accordingly, R t may be kept decreasing by varying k as discussed in the first half of this section that is by keeping τ k,p,σ constant or increasing. However, in practice, increasing k may eventually become infeasible. At that point, the force of testing will decrease, hence, R t may increase temporarily, within the bounds given in (5), despite the constantly decreasing number of susceptible individuals S(t).

A reasonable goal for the authorities is to keep R t close to a designated value, ideally close to 1 to suppress the epidemic. Running estimates of the actual R t might be obtained [19, 27, 28] , hence, we investigate if, by an increase of the testing rate, we can alter R t as desired.

Proposition 3.4. Let 0 ≤ k 1 ≤ k 2 be two testing rates. Consider an epidemic described by (1) with daily testing rate k 1 , and the associated effective reproduction number R t (k) as a function of k.

Then, the ratio of the effective reproduction numbers corresponding to altering the testing rate from k 1 to k 2

satisfies the following inequality

Proof. The right bound is trivial as R t is monotonic in k. Now, observe that

The first term is ≥ 1, thus,

using the monotonicity of f (x) noted at the beginning of this section.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . Now, consider reordering the product as

Again, the first term is ≥ 1, therefore,

holds using, again, the monotonicity of f (x).

Combining the two inequalities above completes the proof.

The implications of Prop. 3.4 on goals for the testing strategy are rather important as they point out some hard limitations. Clearly, as

no matter our testing capacity or indicator symptom, we may not suppress the epidemic any further. As an example, if our current estimates for R t are above 2.4, then we cannot expect the pure indicator symptom-based testing strategy (without contact-tracing) to be able to suppress the epidemic as 2.4 · 0.43 ∼ 1.03. Additionally, as the indicator symptom limits our testing rate to k ≤ Σ = pI + σ, we obtain another hard constraint, namely,

that is the ratio describing what proportion of the primary symptom pool is being tested directly limits the factor which the effective reproduction number may be decreased with via larger testing rates. Finally, we note that reordering the inequality yields k 2 ≥ k 1 r as a lower requirement for the required testing rate -given that the reduction by factor r is achievable.

We have discussed from various aspects that increasing the testing rate k decreases the effective reproduction number R t that is it has a positive effect on the severity of the epidemic. Nevertheless, this positive effect is gradually decreasing as described by the following Proposition.

Proposition 3.5. Consider the logarithmic derivative of R t w.r.t. the testing rate k that is

Then, R * t is negative and monotonically increasing in k.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . https://doi.org/10.1101/2020. 10.11.20211037 doi: medRxiv preprint Proof. Clearly,

Then,

This logarithmic derivative is a measure of the relative change in R t w.r.t. the testing rate k. Prop. 3.5 states that the relative change is decreasing in absolute value as k increases.

This section presents the results from several numerical simulations demonstrating the impact of the key parameters of the epidemic model (1). All simulations were executed with a sample population of size 10, 000, 000 with initial conditions placing 1000 individuals into the class L and the rest into S.

First, Sect. 4.1 presents the numerical analysis of the control reproduction number R c . Then, we investigate the connection between the progress of an outbreak and the positivity rate of testing in Sect. 4.2. We study the implications of maintaining a constant force of testing τ p,k,σ in Sect. 4.3. The significance of the seasonality of the secondary symptom pool σ is analyzed in Sect. 4.4. Finally, in Sect. 4.5, we assess how an increased testing rate may delay the progress of COVID-19.

14 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. The control reproduction number R c , given in (4), describes the initial progress of the epidemic at its very beginning. Fig. 2 demonstrates what effect of indicator symptom-based testing has on R c for various values of R 0 and σ. Clearly, larger maximal testing rate k results in lower R c . The size of the secondary symptom pool σ apparently greatly affects the decrease we may achieve by larger k.

Recall that the positivity rate θ, see (3), is a key feature of the testing strategy that may be readily observed during an outbreak. If the efforts aimed at suppressing COVID-19 are not successful, the rate θ will increase as the term pI(t) will eventually dominate the secondary symptom pool σ. Fig. 3 demonstrates that the changes in θ are in close connection with the dynamics of I(t). This relationship between θ and I(t) carries a certain benefit for the authorities as the increase of the positivity rate precedes that of the epidemic curve, hence, it may serve as a primary indicator for the progress of an epidemic.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. 

As we have discussed in Sect. 3, a constant force of testing τ p,k,σ is achieved by testing a fixed portion of the primary symptom pool Σ, i.e. k Σ is constant. For an ongoing epidemic this results in a constant increase in the required daily testing rate k. We have analyzed the maximal required testing capacity w.r.t. COVID-19 patients in Fig. 4 .

Note that for constant τ p,k,σ , the system (1) is independent of the sec-

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.11.20211037 doi: medRxiv preprint Figure 4 : Required testing capacity to maintain a constant force of testing τ p,k,σ . The vertical axis describes the desired portion for testing the primary symptom pool and the horizontal axis represents the underlying basic reproduction number R 0 . The prevalence of the indicator symptom is set to p = 0.1.

ondary symptom pool σ, thus, this requirement must be adjusted based on historical data on the size of σ to obtain the total maximal required capacity.

Now, let us investigate the epidemic curves in case of a periodically varying secondary symptom pool. To that end, we employ a commonly used seasonality function Figure 6 : The impact of seasonal σ with minimal size at the beginning of the outbreak. R 0 = 1.9, p = 0.1, k = 10,000, σ = 10,000. The blue curve corresponds to assuming a constant (average) secondary symptom pool, whilst, the red curve depicts the effect of seasonality. Fig. 6 demonstrates the effect of having seasonality in σ and the COVID-19 outbreak beginning around the minimal size of the secondary symptom pool. This comparison shows that we may expect a slight, but notable, delay in this scenario compared to the non-seasonal setting.

A similar shift in the opposite direction takes place if we consider the 18 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.11.20211037 doi: medRxiv preprint beginning of the outbreak to coincide with the maximal state of σ, see Fig. 7 . 

Increasing the testing rate k has a beneficial effect. We demonstrate this via transitional plots on Fig. 8 . Note that a larger maximal k both delays in time and decreases in size the peak of the epidemic. Figure 8 : The impact of increasing the testing rate from 1,000 (red) to 10,000 (blue) using parameters R 0 = 1.6, p = 0.1, 1, 000 ≤ k ≤ 10,000, σ = 10,000.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 14, 2020. . https://doi.org/10.1101/2020.10.11.20211037 doi: medRxiv preprint

We have investigated the effects of indicator symptom-based testing on COVID-19. The benefits of increasing the testing rate k are demonstrated, suggesting that, as long as other logistical constraints allow, the authorities should aim to keep it as high as possible. The choice of the indicator symptom is of importance. We have shown that not just its prevalence p should be taken into account but the size and seasonality of the associated secondary symptom pool σ as well. Note that the analysis in this chapter did not directly consider contact/transmission-reducing nonpharmaceutical interventions (NPIs), i.e. curfew, closures of schools, wearing of masks, etc. Naturally, these interventions would affect not just the spread of COVID-19, but of other diseases, hence, potentially decreasing the secondary symptom pool σ as well. Such NPIs may be fitted into the presented framework by varying the basic reproduction number R 0 and σ, as seen in Sect. 4.1.

The quality of tests was not considered. The false negativity rate could be easily modeled by a reduction factor in k. Handling the false positivity rate is more involved as susceptible individuals (susceptible to COVID-19, but still displaying the indicator symptom, i.e. members of σ) may be temporarily removed from the infectious chain just to reappear later, after a precautionary quarantine. However, rRT-PCR-tests have very high specificity, hence, false positives are rare.

We have modeled the transmission of COVID-19 using identical rates for the presymptomatic P and symptomatic I classes. This choice is influenced by the current understanding that according to the inferred infectivity profiles, the transmissibility prior to and after the onset of symptoms is of similar magnitude, and the ratio of presymptomatic transmissions is almost 50% [3, 4, 5] . Nevertheless, using different rates for the two compartments would not alter the computations heavily.

It is clear from the numerical simulations that indicator symptom-based testing, alone, cannot prevent an outbreak. It has a modest effect in delaying and slowing down the epidemic. Thus, symptom based testing alone may have clinical importance by providing guidance about how to treat a given patient, but its impact as epidemic mitigation is negligible. Therefore, in practice, authorities should opt to perform agile contact-tracing based on positive COVID-19 tests. The effect of this additional intervention is not included in our analysis. Nevertheless, it is safe to claim that the addition of contact-tracing would considerably increase the benefits of any testing strategy, in particular, some individuals would get removed from the presymptomatic compartment P and the latent compartment L as well via 20 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 14, 2020. . additional testing or general quarantine for contacts of COVID-19 patients with positive test result.

In summary, testing and isolation of cases is a key tool in combating the pandemic. However, symptom-based testing alone is not sufficient to control COVID-19. To significantly ease the disease burden on the society, it must be used in combination with other measures.

2019-nCoV): situation reports. World Health Organization 2020

Clinical features of COVID-19

Temporal dynamics in viral shedding and transmissibility of COVID-19

COVID-19 infectivity profile correction

Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

Clinical characteristics of COVID-19. European Centre for Disease Prevention and Control

Clinical Characteristics of Coronavirus Disease 2019 in China

Real-time tracking of self-reported symptoms to predict potential COVID-19

Real-Time RT-PCR Panel for Detection 2019-nCoV

Global dynamics of a SEIR model with varying total population size

Applications of epidemiological models to public health policymaking: the role of heterogeneity in model predictions

Nonlinear model predictive control for COVID-19 management

A mathematical model for the novel coronavirus epidemic in Wuhan

Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China

An SEIR Infectious Disease Model with Testing and Conditional Quarantine

COVID-19 Epidemic Risk Assessment for Georgia

Early phase of the COVID-19 outbreak in Hungary and post-lockdown scenarios

Influenza Seasonality: Underlying Causes and Modeling Theories

Seasonal patterns of gastrointestinal illness

Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy

Modeling the spread of COVID-19 in Germany: Early assessment and possible scenarios

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

The construction of next-generation matrices for compartmental epidemic models

SARS outbreaks in Ontario, Hong Kong and Singapore: the role of diagnosis and isolation as a control mechanism

A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics

How Generation Intervals Shape the Relationship Between Growth Rates and Reproductive Numbers